{"id":24328,"date":"2025-06-10T11:53:45","date_gmt":"2025-06-10T09:53:45","guid":{"rendered":"https:\/\/ibsal.es\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\/"},"modified":"2026-08-04T12:53:35","modified_gmt":"2026-08-04T10:53:35","slug":"ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024","status":"publish","type":"post","link":"https:\/\/ibsal.es\/en\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\/","title":{"rendered":"IBSAL has published 632 scientific papers and has secured 114 new competitive projects and 107 clinical trials in 2024"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Luis Garc\u00eda Ortiz, scientific director of the Salamanca Institute for Biomedical Research, highlighted the efforts of the research and management teams during the 4th Scientific Conference, which brought together 300 participants at the Castilla y Le\u00f3n Exhibition and Convention Center<\/strong>.<\/p>\n\n<div style=\"height:26px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p class=\"wp-block-paragraph\"><strong>Mart\u00edn G\u00f3mez Redondo, speaking on behalf of the pre-doctoral researchers, emphasizes that this event \u201chighlights the enormous daily effort behind the knowledge we generate\u201d and describes it as \u201can essential opportunity to grow as scientists.\u201d<\/strong><\/p>\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p class=\"wp-block-paragraph\">The Salamanca Biomedical Research Institute (IBSAL)\u2014the Department of Health of the Regional Government of Castile and Le\u00f3n, the University of Salamanca (USAL), and the Spanish National Research Council (CSIC) \u2014 closes out 2024 with an outstanding record of scientific, educational, and administrative activity, including <strong>632 scientific publications, 114 new competitively funded projects, 107 new clinical trials, and 89 doctoral dissertations defended<\/strong>\u2014figures that solidify its position as a leader in biomedical research.<\/p>\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p class=\"wp-block-paragraph\">During the opening ceremony of the <strong>4th Scientific Conference<\/strong>, IBSAL\u2019s scientific director, <strong>Luis Garc\u00eda Ortiz<\/strong>, noted that \u201c2024 has been a year of intense activity and changes at the institute, both in management and in scientific areas. \u201cWe have all worked hard to implement the changes recommended in the recent reaccreditation\u201d as a health research institute by the ISCIII, which was granted in February 2024 for a period of five years.<\/p>\n\n<div style=\"height:26px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p class=\"wp-block-paragraph\">In this regard, he wished to acknowledge <strong>the collective effort of the 1,422 people who make up IBSAL<\/strong>: \u201cI would like to thank everyone for their work in bringing about these changes\u2014including management staff, department coordinators, platform managers, committee coordinators, and all researchers\u2014for their hard work and for their excellent reception of the changes implemented, which have allowed us to adapt to the institute\u2019s new requirements.\u201d<\/p>\n\n<div style=\"height:26px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p class=\"wp-block-paragraph\">In the area of training, IBSAL has organized <strong>30 courses, 31 seminars, and 17 workshops<\/strong>, in addition to 28 courses and one workshop held in <strong>collaboration<\/strong> with other organizations <strong>with the University Hospital of Salamanca. A total of 59 have also been conducted <\/strong>  research stays.<\/p>\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p class=\"wp-block-paragraph\">Of the 114 competitive projects, 82 are managed directly by IBSAL, representing a 32% increase from the 62 projects in the previous year. In total, the institute has 254 active projects, with 170 under its direct management. In the area of clinical research, 107 new clinical studies have been launched (86 clinical trials and 21 observational studies). This brings the total number of active studies to 581: 450 clinical trials and 131 observational studies.Regarding scientific output, of the 632 total publications, 594 are original articles and reviews, of which 23% appear in Decile 1 (D1) journals, 64% in the first quartile (Q1), and 17% in the second quartile (Q2), demonstrating the high impact of the research conducted, with <strong>more than 80% of its publications<\/strong> appearing <strong>in high-impact journals worldwide<\/strong>.   <\/p>\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p class=\"wp-block-paragraph\">The 4th Scientific Conference, which brings together <strong>300 researchers at the Salamanca Convention and Exhibition Center<\/strong>, kicked off with the Young Researchers\u2019 Meeting and an exhibition of the eight papers selected from among the <strong>73 submitted by the Institute\u2019s trainees<\/strong>, of which another 40 were presented in poster format.<\/p>\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p class=\"wp-block-paragraph\">In his welcome address, <strong>Luis Garc\u00eda Ortiz also <\/strong>highlighted the involvement of younger researchers, who \u201cthrough the Predoc Community, are demonstrating how well they have integrated into the institute, as well as their excellent preparation, as evidenced by the quality of the papers presented at this conference.\u201d He also highlighted the new format of this year\u2019s conference, \u201cthrough which we have sought to bring together young and senior researchers to foster collaboration among them and leverage the expertise of the three guest speakers to explore the topic of open science in greater depth.\u201d <\/p>\n\n<div style=\"height:29px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p class=\"wp-block-paragraph\">Later, <strong>Mart\u00edn G\u00f3mez Redondo<\/strong>, a representative of the pre-doctoral researchers, stated that \u201cthis event is essential for researchers like us who are in the early stages of our careers, as it allows us to share our research and our first steps in science. It helps us grow as scientists, learn from other researchers, and highlight the enormous daily effort behind the knowledge we generate.\u201d<\/p>\n\n<div style=\"height:28px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p class=\"wp-block-paragraph\">Alba Torres Valle, Enrique Jim\u00e9nez Madrona, Mar\u00eda Mart\u00ednez Fern\u00e1ndez, Joana del Valle Mercado Hern\u00e1ndez, Luc\u00eda Fern\u00e1ndez Fr\u00edas, Araceli Sama Barroso, Yoan Reynaldo Torres Cruz, and Sara Mar\u00eda Vicente Gabriel have presented oral presentations on their work covering a variety of highly topical scientific subjects within each of IBSAL\u2019s research areas: Cancer; Cardiovascular, Renal, and Respiratory Diseases; Neuroscience; Infectious, Inflammatory, and Metabolic Diseases; Gene and Cell Therapy and Transplants; and Primary Care, Public Health, and Pharmacology.<\/p>\n\n<div style=\"height:26px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p class=\"wp-block-paragraph\">Following the official opening of this 4th Scientific Conference, attended by  <strong>Sonia Mart\u00edn P\u00e9rez<\/strong>, Director General of Health Planning, Research, and Innovation for the Regional Government of Castile and Le\u00f3n, and  <strong>Jos\u00e9 Miguel Mateos Roco<\/strong>, Vice Rector for Research and Technology Transfer at the University of Salamanca, as well as Luis Garc\u00eda Ortiz, who presented the  <strong>Institute Report  <\/strong>for the year 2024, some of the  <strong>the most notable projects at the national level, coordinated by IBSAL<\/strong>, such as the Diagnostic and Therapeutic Approach to Renal Fragility; the UMBRELLA-SUMMA Legacy to improve the management of myelodysplastic syndromes; and the clinical trial on CARTemis-1 to treat patients with relapsed multiple myeloma. Similarly, <strong>the Institute\u2019s support platforms<\/strong> will be presented during the conference, including those for Clinical Epidemiology and Methodology, REDCap, Bioinformatics, Clinical Trials, Biomodels, and Biobanks. <\/p>\n\n<div style=\"height:28px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p class=\"wp-block-paragraph\">The planned agenda is rounded out with a roundtable discussion on the <strong><em>National Science Strategy and Research Evaluation <\/em><\/strong>moderated by <strong>\u00c1ngeles Almeida<\/strong>, deputy scientific director of IBSAL, with the participation of <strong>Pilar Rico Castro<\/strong>, head of the Open Science Unit at FECYT; <strong>Paula Adam Bernad<\/strong>, Director of the Research Laboratory at the Catalan Agency for Health Quality and Assessment (AQuAS); and <strong>Pilar Gayoso Diz<\/strong>, Deputy Director General at the Carlos III Health Institute, who will also be responsible for closing the 4th IBSAL Scientific Conference this afternoon.<\/p>\n\n<div style=\"height:24px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p class=\"wp-block-paragraph\"><strong>IBSAL<\/strong><\/p>\n\n<p class=\"wp-block-paragraph\">The Institute of Biomedical Research of Salamanca (IBSAL) was established on March 21, 2011 through an agreement signed by the Ministry of Health of the Regional Government of Castilla y Le\u00f3n and the University of Salamanca, which was joined in February 2012 by the Spanish National Research Council (CSIC). It integrates and coordinates the biosanitary research carried out at the University Hospital of Salamanca, the Primary Care Management of Salamanca and the biosanitary area of the University of Salamanca, including the Institute of Neurosciences of Castilla y Le\u00f3n and the Institute of Molecular and Cellular Biology of Cancer. <\/p>\n\n<div style=\"height:26px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p class=\"wp-block-paragraph\">Its scientific activity is organized into six areas, comprising a total of 85 research groups: Cancer (23 groups); Cardiovascular, Renal, and Respiratory (11); Neuroscience (12); Infectious, Inflammatory, and Metabolic Diseases (19); Gene and Cell Therapy and Transplants (6); and Primary Care, Public Health, and Pharmacology (14).<\/p>\n\n<div style=\"height:27px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p class=\"wp-block-paragraph\"><strong>More information and contact details<\/strong>:<\/p>\n\n<p class=\"wp-block-paragraph\">comunicacion@ibsal.es<\/p>\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Luis Garc\u00eda Ortiz, scientific director of the Salamanca Institute for Biomedical Research, highlighted the efforts of the research and management teams during the 4th Scientific Conference, which brought together 300 [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":12409,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_tribe_ticket_capacity":"","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"categories":[238],"tags":[240],"class_list":["post-24328","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-ibsal-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.12 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>IBSAL has published 632 scientific papers and has secured 114 new competitive projects and 107 clinical trials in 2024 | IBSAL<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibsal.es\/en\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IBSAL has published 632 scientific papers and has secured 114 new competitive projects and 107 clinical trials in 2024\" \/>\n<meta property=\"og:description\" content=\"Luis Garc\u00eda Ortiz, scientific director of the Salamanca Institute for Biomedical Research, highlighted the efforts of the research and management teams during the 4th Scientific Conference, which brought together 300 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibsal.es\/en\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\/\" \/>\n<meta property=\"og:site_name\" content=\"IBSAL\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-10T09:53:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-04T10:53:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ibsal.es\/wp-content\/uploads\/2025\/06\/IMG-20250610-WA0008.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2048\" \/>\n\t<meta property=\"og:image:height\" content=\"1201\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sergi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sergi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\\\/\"},\"author\":{\"name\":\"Sergi\",\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/#\\\/schema\\\/person\\\/34ba5672452d5f86b117e6cb49a6bb97\"},\"headline\":\"IBSAL has published 632 scientific papers and has secured 114 new competitive projects and 107 clinical trials in 2024\",\"datePublished\":\"2025-06-10T09:53:45+00:00\",\"dateModified\":\"2026-08-04T10:53:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\\\/\"},\"wordCount\":1114,\"image\":{\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ibsal.es\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/IMG-20250610-WA0008.jpg\",\"keywords\":[\"IBSAL\"],\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\\\/\",\"url\":\"https:\\\/\\\/ibsal.es\\\/en\\\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\\\/\",\"name\":\"IBSAL has published 632 scientific papers and has secured 114 new competitive projects and 107 clinical trials in 2024 | IBSAL\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ibsal.es\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/IMG-20250610-WA0008.jpg\",\"datePublished\":\"2025-06-10T09:53:45+00:00\",\"dateModified\":\"2026-08-04T10:53:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/#\\\/schema\\\/person\\\/34ba5672452d5f86b117e6cb49a6bb97\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ibsal.es\\\/en\\\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ibsal.es\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/IMG-20250610-WA0008.jpg\",\"contentUrl\":\"https:\\\/\\\/ibsal.es\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/IMG-20250610-WA0008.jpg\",\"width\":2048,\"height\":1201},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/ibsal.es\\\/en\\\/institute-of-biomedical-research-of-salamanca\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IBSAL has published 632 scientific papers and has secured 114 new competitive projects and 107 clinical trials in 2024\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/ibsal.es\\\/en\\\/\",\"name\":\"IBSAL\",\"description\":\"Benchmarks in translational research in biomedicine in Castilla y Le\u00f3n\",\"alternateName\":\"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibsal.es\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ibsal.es\\\/en\\\/#\\\/schema\\\/person\\\/34ba5672452d5f86b117e6cb49a6bb97\",\"name\":\"Sergi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/528ac3b73275e0b7aaacef0c293ace2a4935f7e6f58f8b31465b2faf9ae5ed56?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/528ac3b73275e0b7aaacef0c293ace2a4935f7e6f58f8b31465b2faf9ae5ed56?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/528ac3b73275e0b7aaacef0c293ace2a4935f7e6f58f8b31465b2faf9ae5ed56?s=96&d=mm&r=g\",\"caption\":\"Sergi\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"IBSAL has published 632 scientific papers and has secured 114 new competitive projects and 107 clinical trials in 2024 | IBSAL","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibsal.es\/en\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\/","og_locale":"en_US","og_type":"article","og_title":"IBSAL has published 632 scientific papers and has secured 114 new competitive projects and 107 clinical trials in 2024","og_description":"Luis Garc\u00eda Ortiz, scientific director of the Salamanca Institute for Biomedical Research, highlighted the efforts of the research and management teams during the 4th Scientific Conference, which brought together 300 [&hellip;]","og_url":"https:\/\/ibsal.es\/en\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\/","og_site_name":"IBSAL","article_published_time":"2025-06-10T09:53:45+00:00","article_modified_time":"2026-08-04T10:53:35+00:00","og_image":[{"width":2048,"height":1201,"url":"https:\/\/ibsal.es\/wp-content\/uploads\/2025\/06\/IMG-20250610-WA0008.jpg","type":"image\/jpeg"}],"author":"Sergi","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Sergi","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ibsal.es\/en\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\/#article","isPartOf":{"@id":"https:\/\/ibsal.es\/en\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\/"},"author":{"name":"Sergi","@id":"https:\/\/ibsal.es\/en\/#\/schema\/person\/34ba5672452d5f86b117e6cb49a6bb97"},"headline":"IBSAL has published 632 scientific papers and has secured 114 new competitive projects and 107 clinical trials in 2024","datePublished":"2025-06-10T09:53:45+00:00","dateModified":"2026-08-04T10:53:35+00:00","mainEntityOfPage":{"@id":"https:\/\/ibsal.es\/en\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\/"},"wordCount":1114,"image":{"@id":"https:\/\/ibsal.es\/en\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/ibsal.es\/wp-content\/uploads\/2025\/06\/IMG-20250610-WA0008.jpg","keywords":["IBSAL"],"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/ibsal.es\/en\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\/","url":"https:\/\/ibsal.es\/en\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\/","name":"IBSAL has published 632 scientific papers and has secured 114 new competitive projects and 107 clinical trials in 2024 | IBSAL","isPartOf":{"@id":"https:\/\/ibsal.es\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ibsal.es\/en\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\/#primaryimage"},"image":{"@id":"https:\/\/ibsal.es\/en\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/ibsal.es\/wp-content\/uploads\/2025\/06\/IMG-20250610-WA0008.jpg","datePublished":"2025-06-10T09:53:45+00:00","dateModified":"2026-08-04T10:53:35+00:00","author":{"@id":"https:\/\/ibsal.es\/en\/#\/schema\/person\/34ba5672452d5f86b117e6cb49a6bb97"},"breadcrumb":{"@id":"https:\/\/ibsal.es\/en\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibsal.es\/en\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ibsal.es\/en\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\/#primaryimage","url":"https:\/\/ibsal.es\/wp-content\/uploads\/2025\/06\/IMG-20250610-WA0008.jpg","contentUrl":"https:\/\/ibsal.es\/wp-content\/uploads\/2025\/06\/IMG-20250610-WA0008.jpg","width":2048,"height":1201},{"@type":"BreadcrumbList","@id":"https:\/\/ibsal.es\/en\/ibsal-has-published-632-scientific-papers-and-has-secured-114-new-competitive-projects-and-107-clinical-trials-in-2024\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ibsal.es\/en\/institute-of-biomedical-research-of-salamanca\/"},{"@type":"ListItem","position":2,"name":"IBSAL has published 632 scientific papers and has secured 114 new competitive projects and 107 clinical trials in 2024"}]},{"@type":"WebSite","@id":"https:\/\/ibsal.es\/en\/#website","url":"https:\/\/ibsal.es\/en\/","name":"IBSAL","description":"Benchmarks in translational research in biomedicine in Castilla y Le\u00f3n","alternateName":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibsal.es\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ibsal.es\/en\/#\/schema\/person\/34ba5672452d5f86b117e6cb49a6bb97","name":"Sergi","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/528ac3b73275e0b7aaacef0c293ace2a4935f7e6f58f8b31465b2faf9ae5ed56?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/528ac3b73275e0b7aaacef0c293ace2a4935f7e6f58f8b31465b2faf9ae5ed56?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/528ac3b73275e0b7aaacef0c293ace2a4935f7e6f58f8b31465b2faf9ae5ed56?s=96&d=mm&r=g","caption":"Sergi"}}]}},"_links":{"self":[{"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/posts\/24328","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/comments?post=24328"}],"version-history":[{"count":1,"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/posts\/24328\/revisions"}],"predecessor-version":[{"id":24330,"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/posts\/24328\/revisions\/24330"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/media\/12409"}],"wp:attachment":[{"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/media?parent=24328"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/categories?post=24328"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibsal.es\/en\/wp-json\/wp\/v2\/tags?post=24328"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}